Navigation Links
Kips Bay Medical, Inc. Announces Pricing of its Initial Public Offering of Common Stock
Date:2/10/2011

MINNEAPOLIS, Feb. 10, 2011 /PRNewswire/ -- Kips Bay Medical, Inc. (Nasdaq: KIPS) announced today the pricing of the Company's initial public offering of 2,062,500 shares of its common stock at a price of $8.00 per share.  The shares are expected to begin trading on February 11, 2011 on the NASDAQ Global Market under the ticker symbol "KIPS."  The closing of the offering is scheduled to take place on February 16, 2011.  The Company has granted the underwriters a 45-day option to purchase up to an additional 309,375 shares of common stock at the initial public offering price to cover over-allotments, if any.  The Company intends to use the proceeds of the offering to fund the process of seeking regulatory approval to market its external saphenous vein support technology, or eSVS MESH, in the United States, to fund the development and testing of additional applications of its eSVS MESH, to fund certain milestone payments related to acquired intellectual property, and the remainder, if any, for working capital and general corporate purposes.

Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc. (Nasdaq: RODM), is acting as sole book-running manager of the offering and Newbridge Securities Corporation, Caris & Company and Chardan Capital Markets, LLC are acting as co-managers.  This offering is being made solely by means of a prospectus.  Copies of the final prospectus relating to the offering, when available, may be obtained from Rodman & Renshaw, LLC at 1251 Avenue of the Americas, New York, NY 10020, via telephone at (212) 430-1710, via email to prospectus@rodm.com or by visiting the U.S. Securities and Exchange Commission website at http://www.sec.gov.


'/>"/>
SOURCE Kips Bay Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cayenne Medical, Inc. Appoints David B. Springer President & CEO
2. Frost & Sullivan Recognizes Cohera Medical, Inc.® for Developing TissuGlu®, Its Pioneering Surgical Adhesive That Is Strong, Easy-To-Use, Biocompatible and Resorbable
3. Nonin Medical, Inc. Launches New WristOx2™, Model 3150 in U.S. and Canada
4. Kevin Banion Named CEO of Progressive Medical, Inc.
5. Solta Medical, Inc. Appoints Thomas J. Yorkey, Ph.D. to Vice President of Research & Development
6. BioDrain Medical, Inc. Is Eligible for Trading on the OTCBB, Notice of Allowance on Canadian Patent Application
7. Audax Medical, Inc. Receives Therapeutic Discovery Grant for Development of Regenerative Bone Material
8. Audax Medical, Inc. Secures Exclusive Rights to Novel Osteobiologic Nanotechnology
9. Prescient Medical, Inc. Presenting at the 5th Annual Canaccord Genuity Cardiovascular Conference
10. Cayenne Medical, Inc. Reaches 50,000 Implant Milestone
11. A Platform Technology to Address Bioterrorism Released by Aethlon Medical, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... N.J. , March 27, 2015  Johnson & Johnson ... Shareholders at 10 a.m. (Eastern Time) on Thursday, April 23, ... N.J. Investors and other interested parties ... visiting the Company,s website at www.jnj.com and clicking ... from the meeting will be made available a few hours ...
(Date:3/27/2015)... , March 27, 2015  WebMD Health ... source of health information, today announced an ... National Action Plan for Combating Antibiotic-Resistant ... emphasized the urgency and importance of addressing ... and global health.    The WebMD ...
(Date:3/26/2015)... WASHINGTON , March 26, 2015 "Whether ... potentially patients one day." In a single ... and chief scientific officer at Pfizer,s Centers for ... researchers and scientists fueling progress at America,s biopharmaceutical companies. ... to work side-by-side with academia, patient foundations and the ...
Breaking Medicine Technology:Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 2Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 3Collaboration for Cures: Teaming Up to Advance Science and Save Lives 2
... Results from two prospective, double-blind placebo controlled multi-center ... pooled European efficacy and safety data in patients with ... presented at the American Academy of Neurology,s (AAN) 61st ... by Merz Pharmaceuticals, which plans to file a Biologic ...
... AS, the human antibody,therapeutics company, announced today that ... were presented by its,collaboration partner Peregrine Pharmaceuticals at ... Cancer Research (AACR) 2009 held during April,18 - ... of PGN635 and PGN632,provided further confirmatory evidence that ...
Cached Medicine Technology:Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients 2Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients 3Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients 4Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients 5Affitech-Discovered Anti-PS Antibodies in Development by Peregrine Pharmaceuticals Show Excellent Functionality in Preclinical Studies 2
(Date:3/28/2015)... March 28, 2015 Take a bite ... kicks into action. Acids tumble into the stomach, ready ... faulty valve-like structure lets these acids run amok, triggering ... extremely common symptom. More than 60 million Americans have ... examine where heartburn starts, and how it can be ...
(Date:3/28/2015)... 28, 2015 Emergency Medical Care (EMC), ... in Manhattan, recently commemorated its three-year anniversary of being ... In addition to 24-hour urgent care, Emergency Medical Care ... At this time, Emergency Medical Care’s Urgent Care ... chest pain, eye injuries, ear infections, fevers, insect bites, ...
(Date:3/28/2015)... March 28, 2015 Pitching speed, player’s height, ... of shoulder and elbow injuries, according to new research released ... AOSSM ) Specialty Day. , “Our findings indicate that a ... increase in likelihood of a history of injury, a 10 ... 12% increase likelihood of a history of injury, and playing ...
(Date:3/28/2015)... NV (PRWEB) March 28, 2015 Early ... patients with Type V AC joint injuries, according to ... presented today at the American Orthopaedic Society for Sports ... returned to duty faster when surgery was not performed. ... with 7 receiving surgical treatment and 17 receiving non-surgical ...
(Date:3/28/2015)... Aureus Medical Group (web: aureusmedical.com), ... therapy jobs, has announced that it will participate ... Association Annual Conference to be held April 10-11, ... Columbus, OH. , The OPTA Annual Conference ... products and services. , Representatives from Aureus ...
Breaking Medicine News(10 mins):Health News:Bypass Your Heartburn Worries This Easter With Tylers Coffee 2Health News:Emergency Medical Care Celebrates Three Years of 24/7 Walk-In Urgent Care Services 2Health News:Researchers Highlight Shoulder and Elbow Injury Possibility in Youth Players 2Health News:For Type V AC Joint Injuries, Early Surgery May Not Be the Best Approach 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2
... HealthDay Reporter , MONDAY, Nov. 8 (HealthDay News) -- ... must make in order to breast-feed is their sleep. But ... The study, published online Nov. 8 in the journal ... amount of time whether they were breast-feeding or formula-feeding. ...
... The use of statins among a group of postmenopausal ... to the results of a prospective analysis of data from ... results of our study are consistent with the majority of ... among users of statins," said Michael S. Simon, M.D., professor ...
... found that chemicals used to line junk food wrappers ... being ingested by people where they are contributing to ... acids or PFCAs are the breakdown products of chemicals ... ranging from kitchen pans to clothing to food packaging. ...
... (HealthDay News) -- Among certain patients with a history ... Pradaxa (dabigatran) appears to be as effective as the ... German research reveals. Specifically, the new study suggests ... stroke as effectively as warfarin among those facing an ...
... Breast cancer patients are more likely to have joint pain ... cancer, according to a study presented at the American College ... study is one of the first to identify factors that ... from AI therapy. AIs, the standard adjuvant therapy for ...
... an amphibious fish stays alive for up to two months on ... fishonly about an inch or two longthat live in temporary pools ... Florida. During dry seasons when their pools disappear, the fish hole ... stay moist, they can survive for extended periods out of water ...
Cached Medicine News:Health News: Breast-Feeding Won't Rob Mom of Sleep: Study 2Health News: Breast-Feeding Won't Rob Mom of Sleep: Study 3Health News:Statins did not reduce colorectal cancer in WHI analysis 2Health News:Dangerous chemicals in food wrappers likely migrating to humans: U of T study 2Health News:New Drug, Pradaxa, May Prevent Second Stroke in Certain Heart Patients 2Health News:New Drug, Pradaxa, May Prevent Second Stroke in Certain Heart Patients 3Health News:Study sheds light on aromatase inhibitor joint pain syndrome 2Health News:Study sheds light on aromatase inhibitor joint pain syndrome 3Health News:Special skin keeps fish species alive on land 2
Angled 45 degree shafts with 10.5 mm tying and 1 mm of tip crisscross serrated. Serrated handle with dull finish. Manufactured in titanium. Overall length 3.2 inches....
Straight, 7 mm tying platform. Castroviejo handle. Manufactured in titanium. Overall length 4.2 inches....
Straight shafts with 6 mm tying platform. Wide serrated handle with polished finish. Overall length 4.3 inches. Overall length 4.3 inches....
Curved shafts and tips with 6.5 mm tying platform. Flat serrated handle with dull finish. Overall length 3.9 inches. Overall length 3.9 inches....
Medicine Products: